Editors' Picks
Sarepta Therapeutics: Irrational Exuberance by George Rho
The Haze Lifts: 96% Of Medical Marijuana Inc. Q4 Sales From Questionable Transaction by Alan Brochstein
Molycorp: Are Debt Covenants The 'Smoking Gun?' by Shock Exchange
Investing In Disruptive Business Models: SolarCity And Better Energy by Mike Arnold
Nokia As Comeback King: Using A Grassroots Approach To Win by Transcend Asset
Roundy's Hidden Gem by Nick Patterson
Long Ideas
Kandi Vs. Tesla Wall Street Match-Up Revisited: Exceptional EV Business Execution From Both by Arthur Porcari
Aflac's Moat Explained by Anthony Grossi
Qualcomm: Understanding The Risks Before You Buy by Michael Fu
Muscle Pharm Will 'Bulk Up' Your Returns by Buffett Junior
Valero's Upside Case Has Not Been Reached by Valuentum
How Past Technology Successes Underscore Car Charging Group's Potential by Mars Report
What To Do With Qualcomm by BubbleBustInvesting
Q10 Will Be The Catalyst For The BlackBerry Short Squeeze by Greg Penny
Questcor's Upcoming First Quarter Report: An Investor Reference Guide by Michael Fuller
Wal-Mart Partnership With 'Man Of Steel' A Game Changer And Stepping Stone by Chris Katje
Qualcomm: What The Heck Happened? by Ashraf Eassa
Sirius XM: $3.14 As Shorts Cover 11 Million Shares by Stephen Faulkner
Intel's New Catalysts: Giant Tablets And $200 Android Hybrids by Sneha Shah
Kona Grill Is Cooking Up Monster Returns by Quoth the Raven
Amazon's Digital Media Land Grab: The Kindle TV by Mike Arnold
Renewed Buying Interest In Halozyme After Phase II Initiation by Brian L. Wilson
10 Reasons To Buy The Qualcomm Of Memory by Sneha Shah
Amazon: Is Future Growth Enough To Justify Current Valuation? by IAEResearch
Microsoft's Earnings Report And Its Future - Part 2 by Fundamental Analyst
Gold And Silver Royalty Companies Part 4: Royal Gold, Inc. by Ben Kramer-Miller
Apple: Complete Reset Of Expectations Could Mark The Bottom by Steve Birenberg
United's Operational Performance And Integration Progress In Focus by Trefis
BlackBerry: Bulls Won't Regret It, And Neither Will You by Fusion Research
What Is Going On With Potash Corp.? by Efsinvestment
Meritage Sets The Bar High For Builders by Todd Campbell
ABB Acquires Power-One To Lead Solar Inverter Market by Alpha Hunter
Microsoft's Earnings Report And Its Future - Part 1 by Fundamental Analyst
Chesapeake Energy: Biggest Beneficiary Of Higher Natural Gas Prices by Stone Fox Capital
China Worries Shouldn't Scare Long-Term Investors Away From Yum Brands by Chris Katje
Investing In Disruptive Business Models: SolarCity And Better Energy by Mike Arnold
Is Citigroup Unsustainably Big? by Ed Liston
iRobot Shares Still Undervalued With Earnings Beat And Telemedicine Segment by Chris Katje
Things Are Shaping Up At Kodiak by Marshall Hargrave
Why Lululemon Athletica Is Going To New Highs by Carl Cachia
IBM, And The Private Cloud, Will Get Here by Dana Blankenhorn
Buying Opportunity For Silver Wheaton by Nicholas Pardini
The Long Case For Security National Financial by Jeffrey Andle
Corning: A Nice Quarter With More To Come by Douglas E. Johnston
Nokia As Comeback King: Using A Grassroots Approach To Win by Transcend Asset
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval by PropThink
Ford's Stock: Buy Or Sell? by BubbleBustInvesting
SGOCO Group: Firing On All Cylinders by Evans Capital
Roundy's Hidden Gem by Nick Patterson
Advanced Micro Devices' Embedded Strategy Takes Shape by Tom Luongo
Short Ideas
Sarepta Therapeutics: Irrational Exuberance by George Rho
The Haze Lifts: 96% Of Medical Marijuana Inc. Q4 Sales From Questionable Transaction by Alan Brochstein
Buying Medical Marijuana? You Are Being Robbed by Ashraf Eassa
Irrational Exuberance: Lumber Liquidators Edition by Josh Arnold
Molycorp: Are Debt Covenants The 'Smoking Gun?' by Shock Exchange
Dell's Wounds Are Getting Deeper by Alpha Hunter
Apple: How To Admit You're Out Of Ideas by Karl Denninger
TearLab: Watch For A Sharp Drop On Equity Offering by Richard Pearson
Google's Growth Story Isn't What It Seems by Bill Maurer
Quick Picks & Lists
Medical Marijuana: The Gold Rush Is On by Elite Investor
Yum Brands: Operation Thunder Strikes Back And Expansion Continues by Nick Chiu
The Packaged Food Sector Smackdown by Cory Renauer
2 Unfairly Punished Apple Suppliers by BubbleBustInvesting
Exxon - Buy A Phenomenal Company by Christopher Drose
On High Short Interest Ratios by David Merkel
2 Stocks To Buy, 1 Stock To Sell, What's Next For The Market by The Oxen Group
Undervalued Indicators For Big Oil by Shaun Forney
Have Verizon Shares Peaked? by Profit Fan
5 Undervalued Bakken Plays by Asean Century
Which Apparel Company Should You Buy? by Dieter Plas
The Weekly Dow: 5 Highest-Profit Margin Stocks by Michael Fu
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential by Trade In Mexico
iRobot Bulls Clean Up As Shares Soar After Earnings by Interactive Brokers
Prolific Gold Property Still Producing, But Are Large Nuggets Still To Be Found? by Biz Bluetree
Halliburton: Fundamental Improvements With Short-Term Catalysts by Nick Chiu
Oversold Growth Stocks by Codespeed
Banco Santander, Lloyds And Deutsche Bank: Rebounding For Real? by Nick Chiu
An Island Of Safety In The Financial Sector by Morningstar
5 Stocks Under $5 To Buy With Solid Fundamentals And Upside by David Alton Clark
Quickly Approaching Biopharma Catalyst Events by Scott Matusow
General Electric Vs. Siemens: Which Is The Winning Bet For Now? by Timing Best Buy
Ford Is Finding Its Groove by Bret Jensen
Cramer's Picks
Cramer's Lightning Round - Buy Intel For Cybersecurity (4/24/13) by SA Editor Miriam Metzinger
Cramer's Mad Money - National Lemming Day (4/24/13) by SA Editor Miriam Metzinger
Fund Holdings
Ric Dillon And Diamond Hill Capital's Top Stock Picks by Insider Monkey
Insider Ownership
1 Bank, 1 Electric Utility And 1 Gold Stock With Recent Intensive Insider Buying by Markus Aarnio
1 Retailer, 1 Biotech And 1 Management Services Company With Recent Intensive Insider Selling by Markus Aarnio
IPO Analysis
The Most Unexpected Data Coming Out Of Beijing by Lou Basenese
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario